Swaziland is an inland country in the southern Africa with a population of less than 1.5 million. Human immunodeficiency virus (HIV) is the main public health concern in Swaziland as 27.2% of adults are living with HIV infection. Swaziland is known to have the highest prevalence of HIV infected people in the world. However, this might be changing soon as the incidents of new HIV infection are decreasing and the prevalence of HIV infection are stabilizing. This is due to the multiple well-implemented programs that are targeting the different components of HIV transmission including condom availability, HIV education, sex education, male circumcision, and pre-exposure prophylaxis. Although the prevalence of HIV is stabilizing, there are multi...
Despite the efforts at reducing the rate of HIV infection in South Africa, especially with the Khoma...
Background: HIV is hyperendemic in Swaziland with a prevalence of over 25% among those between the a...
Background: There is robust clinical evidence to support offering early access to antiretroviral tre...
An overview of HIV and AIDS statistics indicates that there were 31.6 million people living with HIV...
An overview of HIV and AIDS statistics indicates that there were 31.6 million people living with HIV...
A public health approach to combination HIV prevention is advocated to contain the epidemic in sub-S...
Despite decades that have passed after its discovery in 1981, Human Immunodeficiency Virus (HIV) and...
Due to its rapid spreading, AIDS has been declared a global epidemic. Especially sub-Saharan Africa ...
The HIV Prevention Trials Network (HPTN) is conducting the HPTN 071 (PopART) study in 21 communities...
Abstract of presentation at the 9th International AIDS Society Conference on HIV Science, July 23-26...
To evaluate the feasibility (population reached, costs) and effectiveness (positivity rates, linkage...
Background: The 2011 Swaziland HIV Incidence Measurement Survey (SHIMS) was conducted as part of a ...
The Population Council is conducting implementation research in Swaziland, in collaboration with loc...
textabstractIntroduction:Swaziland's severe HIV epidemic inspired an early national response since t...
Introduction: HIV/AIDS continues to be amongst the leading causes of morbidity and mortality in Sub-...
Despite the efforts at reducing the rate of HIV infection in South Africa, especially with the Khoma...
Background: HIV is hyperendemic in Swaziland with a prevalence of over 25% among those between the a...
Background: There is robust clinical evidence to support offering early access to antiretroviral tre...
An overview of HIV and AIDS statistics indicates that there were 31.6 million people living with HIV...
An overview of HIV and AIDS statistics indicates that there were 31.6 million people living with HIV...
A public health approach to combination HIV prevention is advocated to contain the epidemic in sub-S...
Despite decades that have passed after its discovery in 1981, Human Immunodeficiency Virus (HIV) and...
Due to its rapid spreading, AIDS has been declared a global epidemic. Especially sub-Saharan Africa ...
The HIV Prevention Trials Network (HPTN) is conducting the HPTN 071 (PopART) study in 21 communities...
Abstract of presentation at the 9th International AIDS Society Conference on HIV Science, July 23-26...
To evaluate the feasibility (population reached, costs) and effectiveness (positivity rates, linkage...
Background: The 2011 Swaziland HIV Incidence Measurement Survey (SHIMS) was conducted as part of a ...
The Population Council is conducting implementation research in Swaziland, in collaboration with loc...
textabstractIntroduction:Swaziland's severe HIV epidemic inspired an early national response since t...
Introduction: HIV/AIDS continues to be amongst the leading causes of morbidity and mortality in Sub-...
Despite the efforts at reducing the rate of HIV infection in South Africa, especially with the Khoma...
Background: HIV is hyperendemic in Swaziland with a prevalence of over 25% among those between the a...
Background: There is robust clinical evidence to support offering early access to antiretroviral tre...